Lecture 21 - Stem Cell Therapy for Hereditary Diseases Flashcards

1
Q

What are the three classes of stem cells?

A
  1. ES cells 2. iPS cells 3. tissue-specific cells *Note: “transit amplifying cells” (TA cells also are featured as treatment.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the distinguishing feature of the cells on the far left and at the top of the image?

A

iPS cells and ES cells can divide indefinitely, a property known as self renewal.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

_____________ stem cells can also self-renew, but have a more limited differentiation potential than ES or iPS cells.

A

Tissue-specific stem cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

The property of “self-renewal” in embryonic stem cells and induced pluripotent stem cells reflects what two features of these cells?

A
  1. Expression of specific genes (cell-intrinsic molecules, such as transcription factors)
  2. Cell location in “stem cell niches” - restricted regions that contain extrinsic molecules required to maintain stem cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are “stem cell niches”?

A

Restricted regions that contain extrinsic molecules required to maintain stem cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Tissue-specific stem cells are present in _______ as well as many adult tissues, where they contribute to continuous replacement of cells.

A

embryos

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

_________ cells can divide a limited number of times and can produce only one or a few types of cells in any specific tissue.

A

Transit amplifying precursor cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

_____ cells have stopped dividing, or have a very limited capacity to divide.

A

Somatic cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Somatic cells have a very limited capacity to divide unless they are manipulated by ___(a)___ or ___(b)___ to become ____(c)___ cells?

A

a) gene transfer
b) environmental factors
c) iPS cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Both intrinsic and extrinsic molecules critical for the maintenance of different types of stem cells has been achieved using what two important approaches?

A
  1. Gene expression profiling - comparing stem cells to more differentiated cells
  2. Gain or loss of function assays in vitro
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How is “gene expression profiling” defined?

A

Comparing stem cells to more differentiated cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Gene expression profiling and gain-of-function/loss-of-function assays are techniques that have provided critical information regarding the mechanism of generating ______ cells.

A

iPS (induced pluripotent) stem cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Introducing a small number of genes (i.e. Oct4/Sox2/lin-28/Klf4) to derive iPS cells from somatic cells of embryos or adults is a process known as ____________.

A

reprogramming

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Cells that had become restricted to divide a limited number of times and generate just one type of cell can acquire many of the properties of ______ cells via the process of reprogramming.

A

ES cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Although ES and iPS cells are pluripotent, different lines of ES/iPS cells derived from specific types of ___________ cells may exhibit hiases in their tendency to generate specific types of cells.

A

somatic cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are 3 general ways stem cells can be manipulated before they are transplanted?

A
  1. Cell sorting (via expression of cell-surface markers)
  2. In-vitro propagation (used with iPS, ES, and tissue-specific cells)
  3. Gene-specific targeting (i.e. CRISPR technology)
17
Q

An example of gene-specific targeting that makes genome editing in human cells more feasible is ________.

A

CRISPR technology

18
Q

Neural stem cells from the human CNS have the ______ phenotype, allowing them to be used with a panel of antibodies and cell sorting (i.e. flow cytometry or FACS) to be selected from a heterogenous cell mixture.

A

antigenic phenotype

19
Q

An alternative to stem cells is ________, also called transdifferentiation.

A

direct lineage conversion

20
Q

What does direct lineage conversion accomplish?

A

conversion of one type of somatic cell into another type of somatic cell

21
Q

With the transdifferentiation approach, a fibroblast can be turned into a neuron using a combination of __________ without going through a stem cell intermediate.

A

transcription factors

22
Q

What are the two advantages of direct lineage conversion (“transdifferentiation”)?

A
  1. Faster than reprograming
  2. Cells can maintain features of “adult” stages
23
Q

What is the main disadvantage of direct lineage conversion (“transdifferentiation”)?

A

the number of appropriate cells generated is limited

24
Q

What mode of inheritance is the hereditary disease “infantile neuronal ceroid lipofuscinosis” (INCL)?

A

autosomal recessive (mutation in CLN1 gene, which encodes PPT1 enzyme)

25
Advantages of using neural stem cells (there are four listed in syllabus!) include that they:
1. migrated extensively from sites of injection 2. differentiate in a region appropriate manner 3. integrate into the host tissue 4. did not form tumors
26
Disadvantages of using neural stem cells is that they are:
1. obtained from human embryos 2. not matched immunologically to the patient (possibility)
27
Which type of cells would eliminate the histocompatibility problem of using neural stem cells in stem cell transplantation therapy for clinical trials of INCL?
use of **iPS cells** would have eliminated the histocompatability problem \*Note: if **ES cells** had been used instead, histocompatability would have still been an issue (embryonic stem cells can have unique immunological features)
28
29
Huntington's disease is a late-onset, autosomal dominant neurological disease associated with loss of ______ in the \_\_\_\_\_\_.
loss of **medium spiny neurons (MSNs)** in the **striatum**
30
One alternative to human fetal tissue is ________ cells induced to differentiate into the precursors of MSNs.
human ES (hES)
31
hES cells would requrie immune suppression when induced to differentiate into the precursors of MSNs. ________ would not.
iPS cells
32
Order the following cells from MOST proliferation and differentiation potential to LEAST: A. iPS cell B. Somatic cell C. Tissue-specific stem cell D. Transit amplifying cell
A\>C\>D\>B
33
The best type of cell for transplantation therapy to treat sickle cell disease is:
**Hematopoietic stem cells** derived from the **sickle cell disease patient's iPS cells** that have been **genome-edited** to correct the beta-globin mutation.
34
Induced pluripotent cells are the product of: A. Germ cell proliferation B. Embryonic cell differentiation C. Somatic cell reprogramming D. Stem cell division
C.
35
Transit-amplifying cells are the product of: A. Germ cell proliferation B. Embryonic cell differentiation C. Somatic cell reprogramming D. Tissue-specific stem cell division
D.